Trial Profile
The Menopause Transition: Estrogen Variability, HPA Axis and Affective Symptoms
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Estradiol (Primary) ; Progesterone (Primary)
- Indications Menopausal syndrome; Perimenopause
- Focus Therapeutic Use
- Acronyms CHANGES
- 24 Mar 2021 Status changed from recruiting to discontinued.
- 12 Mar 2019 Planned End Date changed from 1 Jan 2022 to 1 Dec 2021.
- 12 Jan 2018 Status changed from not yet recruiting to recruiting.